Latest Biogen Idec Stories
CHICAGO, March 11, 2013 /PRNewswire/ -- Zacks Equity Research highlights Winnebago Industries, Inc. (NYSE:WGO) as the Bull of the Day and Gold Fields Limited (NYSE:GFI) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Biogen (Nasdaq:BIIB) and Novartis (NYSE:NVS). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Full analysis of all these stocks is available at http://at.zacks.com/?id=2678....
SAN DIEGO, March 10, 2013 /PRNewswire-USNewswire/ -- The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML). A study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013, suggests that early detection of PML may help improve survival and disability levels. The...
This announcement does not constitute an announcement of a firm intention to make an offer under the Irish Takeover Rules NEW YORK, March 6, 2013 /PRNewswire/ -- RP Management, LLC ("Royalty Pharma") remains committed to acquiring Elan (NYSE: ELN) on the terms set out in the Proposal Announcement of February 25, 2013, but continues to be disappointed that the Board of Elan has not engaged in discussions. Royalty Pharma is ready and able to move quickly to implement an offer and...
- Conference Call Webcast Thursday, February 28, 12:00 p.m. ET at www.isispharm.com CARLSBAD, Calif., Feb. 28, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its 2012 financial results and reviewed the highlights of the year. Isis ended the year in a strong financial position significantly outperforming both its pro forma net operating loss (NOL) guidance and its cash guidance for the year. For the year ended December 31, 2012, Isis had an NOL of...
Announcement Made Under Rule 2.4 of Irish Takeover Rules NEW YORK, Feb. 25, 2013 /PRNewswire/ -- RP Management, LLC ("Royalty Pharma") today announces that contact was made on Monday February 18, 2013 with the Chairman of the Board of Elan Corporation, plc (NYSE: ELN) ("Elan"), followed by a meeting then taking place on Wednesday February 20, 2013, at which an indicative proposal was made to acquire the entire issued and to be issued share capital of Elan (the "Proposal"). Royalty...
CARDIFF, Calif., Feb. 11, 2013 /PRNewswire/ -- NI Research has released the February issue of NeuroPerspective. The issue features a comprehensive review of ALS, and the continuing but frustrating search for a genuinely useful treatment for the treatment of this devastating illness. "Just as Alzheimer's slowly erases memory and personality, ALS gradually destroys muscle control, leaving patients almost invariably doomed to death from respiratory failure. The Phase III failure of...
NEW YORK, February 7, 2013 /PRNewswire/ -- Zynga reported fourth-quarter earnings and sales late Tuesday, revealing that the Company earned 1 cent per share, or $6.9 million, on sales of $311 million last quarter. Analysts polled by Thomson Reuters expected a loss of 3 cents per share and $212 million in revenue. The Company's tally of daily active users rose to 56 million in the fourth quarter of 2012 meaning 2 million new daily active users were added in the last year....
SAN DIEGO, Jan. 30, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Professor Bryan R.G. Williams, Ph.D., will not stand for re-election to MEI Pharma's Board of Directors upon the expiration of his term at the Company's next Annual Meeting of Stockholders. Professor Williams has been a member of the Board since March 2006 and has served as Chairman since November 2006....
NEW YORK, January 30, 2013 /PRNewswire/ -- Today, Traders Insight announced new research reports highlighting CVR Energy, Inc. (NYSE: CVI), Youku Tudou Inc. (NYSE: YOKU), Biogen Idec, Inc. (Nasdaq: BIIB), Republic Services, Inc. (NYSE: RSG) and Mobile Mini, Inc. (Nasdaq: MINI). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. CVR Energy, Inc. Research Report CVR Energy,...
LONDON, January 30, 2013 /PRNewswire/ -- EmergingGrowth.com, a leading digital financial media company, discusses Sunesis Pharmaceuticals, Amgen, Inc., Gilead Sciences and Biogen Idec, Inc. The pharmaceutical sector is a very lucrative and competitive industry. And for emerging growth companies, it is difficult to make a meaningful impact in this cutthroat industry. Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) has built a highly experienced cancer drug...
